Methods report on the development of the 2013 revision and update of the EAACI /GA2LEN /EDF /WAO guideline for the definition, classification, diagnosis, and management of urticaria
Author(s) -
Torsten Zuberbier,
Werner Aberer,
Riccardo Asero,
Carsten BindslevJensen,
Ze Brzoza,
Giorgio Walter Caica,
Martin K. Church,
Luís Felipe Ensina,
Ana M. GiménezArnau,
Kiran Godse,
Margarida Gonçalo,
Clive Grattan,
JeanLouis Hébert,
Michihiro Hide,
Allen P. Kaplan,
Alexander Kapp,
Amir Hamzah Abdul Latiff,
P. MathelierFusade,
Martin Metz,
Sarbjit S. Saini,
Mario SánchezBorges,
Peter SchmidGrendelmeier,
F. Estelle R. Simons,
Petra Staubach,
Gordon Sussman,
Elias Toubi,
Ga Vena,
Bettina Wedi,
Xiaoxia Zhu,
Alexander Nast,
Marcus Maurer
Publication year - 2014
Publication title -
allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.363
H-Index - 173
eISSN - 1398-9995
pISSN - 0105-4538
DOI - 10.1111/all.12370
Subject(s) - guideline , european union , medicine , excellence , grading (engineering) , allergy , clinical immunology , library science , family medicine , immunology , political science , computer science , pathology , engineering , business , law , civil engineering , economic policy
This methods report describes the process of guideline development in detail. It is the result of a systematic literature review using the 'Grading of Recommendations Assessment, Development and Evaluation' (GRADE) methodology and a structured consensus conference held on 28 and 29 November 2012, in Berlin. It is a joint initiative of the Dermatology Section of the European Academy of Allergy and Clinical Immunology (EAACI), the EU-funded network of excellence, the Global Allergy and Asthma European Network (GA(2) LEN), the European Dermatology Forum (EDF), and the World Allergy Organization (WAO) with the participation of delegates of 21 national and international societies. This guideline covers the definition and classification of urticaria, taking into account the recent progress in identifying its causes, eliciting factors and pathomechanisms. In addition, it outlines evidence-based diagnostic and therapeutic approaches for the different subtypes of urticaria. This guideline was acknowledged and accepted by the European Union of Medical Specialists (UEMS) and is published in Allergy 2014; 69:868-887.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom